Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
3.320
+0.160 (5.06%)
At close: Oct 3, 2025, 4:00 PM EDT
3.330
+0.010 (0.29%)
After-hours: Oct 3, 2025, 7:43 PM EDT
Alector Revenue
Alector had revenue of $7.87M in the quarter ending June 30, 2025, a decrease of -47.80%. This brings the company's revenue in the last twelve months to $81.13M, up 46.78% year-over-year. In the year 2024, Alector had annual revenue of $100.56M with 3.60% growth.
Revenue (ttm)
$81.13M
Revenue Growth
+46.78%
P/S Ratio
4.05
Revenue / Employee
$340,882
Employees
238
Market Cap
336.02M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 100.56M | 3.50M | 3.60% |
Dec 31, 2023 | 97.06M | -36.56M | -27.36% |
Dec 31, 2022 | 133.62M | -73.47M | -35.48% |
Dec 31, 2021 | 207.09M | 185.99M | 881.54% |
Dec 31, 2020 | 21.10M | -121.00K | -0.57% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ALEC News
- 11 days ago - Alector, Inc. - Special Call - Seeking Alpha
- 18 days ago - Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs - GlobeNewsWire
- 26 days ago - Alector, Inc. (ALEC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Alector to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 2 months ago - Alector, Inc. (ALEC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Alector Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call - GlobeNewsWire
- 4 months ago - Alector Provides Executive Leadership Update - GlobeNewsWire